↓ Skip to main content

Overcoming the challenges of drug development in platinum-resistant ovarian cancer

Overview of attention for article published in Frontiers in oncology, October 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
3 news outlets
twitter
3 X users

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Overcoming the challenges of drug development in platinum-resistant ovarian cancer
Published in
Frontiers in oncology, October 2023
DOI 10.3389/fonc.2023.1258228
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 3 8%
Researcher 3 8%
Unspecified 2 6%
Student > Bachelor 2 6%
Student > Master 1 3%
Other 0 0%
Unknown 25 69%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 3 8%
Unspecified 2 6%
Chemistry 2 6%
Arts and Humanities 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 3 8%
Unknown 24 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2026.
All research outputs
#1,829,785
of 34,145,339 outputs
Outputs from Frontiers in oncology
#387
of 26,492 outputs
Outputs of similar age
#27,241
of 392,328 outputs
Outputs of similar age from Frontiers in oncology
#5
of 929 outputs
Altmetric has tracked 34,145,339 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 26,492 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,328 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 929 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.